Skip to main content

Hepatitis C Virus Treatment

Highly Effective Therapy with Direct Acting Antivirals and Associated Viral Resistance

  • Book
  • © 2017

Access provided by CONRICYT-eBooks

Overview

  • Introduces new therapies available for treating chronic hepatitis C
  • Describes Direct Acting Antiviral Agents (DAA), which have an excellent anti-viral effect on virus replication
  • Provides cutting-edge information not only for hepatologists, but also for researchers, clinical residents, and medical students

Buy print copy

Softcover Book USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

About this book

This book introduces readers to Direct Acting Antiviral (DAAs) agents, newly developed drugs to treat chronic hepatitis C virus infection, which have an excellent anti-viral effect on virus replication. These drugs have been developed to enhance the effect of interferon and ribavirin, as the resistant strains against each drug have been described both in vitro and in vivo and the existences of naturally occurring variants have been reported. However, since the combination of different classes of DAAs is sufficient to completely eradicate the virus without the need for interferon or ribavirin, the current treatment regimen does not include interferon. Ribavirin is used in combination with sofosbuvir, a potent polymerase inhibitor, to enhance its antiviral effects.

Hepatitis C Virus Treatment offers readers a comprehensive guide to hepatitis C; describing the resistance profiles against these drugs and shedding light on the difficulties involved in DAA therapy and the direction of future treatments, it will equip doctors to understand the essentials of treating the disease. It also describes in detail new and innovative DAA treatments, the effects of the agents, and the characteristics of resistance, providing cutting-edge information not only for hepatologists, but also for researchers, clinical residents, and medical students.

Similar content being viewed by others

Keywords

Table of contents (8 chapters)

Editors and Affiliations

  • Department of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan

    Kazuaki Chayama

About the editor

Prof. Kazuaki ChayamaDepartment of Gastroenterology and Metabolism, Applied Life Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University

Bibliographic Information

  • Book Title: Hepatitis C Virus Treatment

  • Book Subtitle: Highly Effective Therapy with Direct Acting Antivirals and Associated Viral Resistance

  • Editors: Kazuaki Chayama

  • DOI: https://doi.org/10.1007/978-981-10-2416-0

  • Publisher: Springer Singapore

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Science+Business Media Singapore 2017

  • Hardcover ISBN: 978-981-10-2415-3Published: 14 November 2016

  • Softcover ISBN: 978-981-10-9610-5Published: 05 July 2018

  • eBook ISBN: 978-981-10-2416-0Published: 01 November 2016

  • Edition Number: 1

  • Number of Pages: VII, 75

  • Number of Illustrations: 9 b/w illustrations, 14 illustrations in colour

  • Topics: Hepatology, Virology, Drug Resistance

Publish with us